CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

Overview Fund Activity
Delisted

CNCR was delisted on the 27th of May, 2025.

Back to rankings

22 hedge funds and large institutions have $8.55M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+2
Holders Change %
+10%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$759K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$550K
3
Royal Bank of Canada
3
Royal Bank of Canada
Ontario, Canada
$583K
4
BL
4
BCWM LLC
Kansas
$4.16M
5
Citadel Advisors
5
Citadel Advisors
Florida
$743K

Top Sellers

1
SG
1
StoneX Group
New York
$0
2
Jane Street
2
Jane Street
New York
$0
3
SWM
3
SeaCrest Wealth Management
New York
$297K
4
Toronto Dominion Bank
4
Toronto Dominion Bank
Ontario, Canada
$0
5
RFWA
5
RPg Family Wealth Advisory
Massachusetts
$80.5K
Name Holding Trade Value Shares
Change 		Shares
Change %
BWA
26
BDO Wealth Advisors
Florida
– -$3K -130 Closed
1
2